Hikma Pharmaceuticals PLC
LSE:HIK
Wall Street
Price Targets
HIK Price Targets Summary
Hikma Pharmaceuticals PLC
According to Wall Street analysts, the average 1-year price target for
HIK
is 2 320.5 GBX
with a low forecast of 1 616 GBX and a high forecast of 2 782.5 GBX.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HIK's stock price target?
Price Target
2 320.5
GBX
According to Wall Street analysts, the average 1-year price target for
HIK
is 2 320.5 GBX
with a low forecast of 1 616 GBX and a high forecast of 2 782.5 GBX.
What is Hikma Pharmaceuticals PLC's Revenue forecast?
Projected CAGR
6%
For the last 14 years the
compound annual growth rate for
Hikma Pharmaceuticals PLC's revenue is
10%.
The projected
CAGR
for the next 3 years is
6%.
What is Hikma Pharmaceuticals PLC's Operating Income forecast?
Projected CAGR
10%
For the last 14 years the
compound annual growth rate for
Hikma Pharmaceuticals PLC's operating income is
14%.
The projected
CAGR
for the next 3 years is
10%.
What is Hikma Pharmaceuticals PLC's Net Income forecast?
Projected CAGR
9%
For the last 14 years the
compound annual growth rate for
Hikma Pharmaceuticals PLC's net income is
14%.
The projected
CAGR
for the next 3 years is
9%.
